532039-BOM

Zenotech Laboratories Ltd.

BSE: 532039

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

44.50-1.9 (-4.03%)

10 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

33.9 / 100

Value Score

25.7 / 100

Price Momentum Score

37.2 / 100

QVM Score

15.2 / 100

Key Metrics

Market Cap

271.59

P/E (TTM)

P/B

2.86

P/S (TTM)

6.23

EV/EBITDA

26.09

CAPE (5Y)

29.16

ROE (TTM)

-1.12

ROCE (TTM)

2.17

ROA (TTM)

-0.97

Avg 3Y ROE

4.83

Earnings 3Y CAGR

-27.95

Sales 3Y CAGR

0.93

Sales 5Y CAGR

17.62

Debt/Equity

0.00

Consensus TP

Strong Buy %

Promoter Holding

68.84

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Zenotech Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.0 as on 31 Mar 2026 and Debt to Equity remained same in the last 1 year

What is Debt to Equity?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -0.39% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low and declining ROE

The company reported low ROE of -1.12% for 12-month ended 31 Mar 2026 and ROE declined by -713 bps from 1 year ago

What is ROE (FY)?

Low and declining operating margin

The company reported low operating margin of 4.76% for 12-month ended 31 Mar 2026 and operating margin declined by -1201 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of 1.32% for 12-month ended 31 Mar 2026 and the growth was 9.92 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 11.24

Value 1.32

-82.35114662

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -119.57% for 12-month ended 31 Mar 2026 and the growth was 127.69 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 59.8 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

59.8 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Zenotech Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Zenotech Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Zenotech Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84
Indian Promoter	57.56	57.56	57.56	57.56	57.56	57.56	57.56	57.56	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84
Foreign Promoter	11.28	11.28	11.28	11.28	11.28	11.28	11.28	11.28	-	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Govt	-	-	-	-	-	-	-	-	-	-	-	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.98
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	31.15	31.15	31.15	31.15	31.15	31.15	31.15	31.15	31.15	31.15	30.17	30.17	30.17	30.17	30.17	30.17	30.17	30.17	30.17	30.17	30.17	30.17	30.17	30.17	30.17
Bodies Corporate	1.71	1.56	1.51	1.41	1.41	1.36	1.47	5.42	5.41	5.41	4.34	4.29	4.31	4.33	4.35	4.42	4.33	4.31	4.32	4.34	4.35	4.37	4.31	4.34	4.34
Others (incl. Retail) No. of shareholders	29.44 6,093	29.59 6,328	29.64 6,322	29.74 6,413	29.74 6,459	29.79 6,687	29.68 7,218	25.73 7,476	25.74 7,680	25.74 7,929	25.83 7,856	25.88 8,674	25.86 9,074	25.84 9,182	25.82 9,524	25.75 9,692	25.84 9,757	25.86 9,685	25.85 10,571	25.83 10,603	25.82 10,626	25.80 10,594	25.86 10,606	25.83 10,401	25.83 10,242

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Zenotech Laboratories Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bharat Jayantilal Patel and Associates

Mar 2026

1.72%

₹ 5 Cr

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Zenotech Laboratories Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

Corporate Actions

History of Zenotech Laboratories Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Rights Issue(17 new shares @ ₹45 for 22 existing shares)
Ex-date: 1st Jun 2017Announced on: 21st May 2017
Others
Ex-date: 17th Jul 2006Announced on: 17th Jul 2006

Company Profile

Overview of Zenotech Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology an...

Key personnel

Dr. Sachin Laxmanappa Gavandare

Chief Executive Officer

Mr. K.V. Poly

Chief Financial Officer

Mr. Abdul Gafoor Mohammad

Chief Compliance Officer, Company Secretary

Mr. Azadar Hussain Asghar Mehdi KhanD

Non-Executive Director

Mr. Jignesh Anantray GoradiaD

Non-Executive Director

Mr. Rakeshchandra Jagdishprasad SinhaD

Non-Executive Director

Mr. Chintan Jitendra ShahD

Non-Executive Independent Director

Smt. Jagruti Prashant ShethD

Non-Executive Independent Director

Incorporated on

15 Jun 1989

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

14 May 1996

Free Float

94,43,839

Website

https://zenotechlab.com/

Phone no.

+914023480431

Address

Survey no 250 -252, Turkapally Village, Shameerpet Mandal, RR District, HYDERABAD, 500078, India

Frequently Asked Questions

What is the current share price of Zenotech Laboratories Ltd.?

The current share price of Zenotech Laboratories Ltd. is ₹ 44.50 as of 10 Jul 2026.

What is the market capitalisation of Zenotech Laboratories Ltd.?

The market capitalisation of Zenotech Laboratories Ltd. stands at ₹ 271.59 Cr.

What is the PE ratio of Zenotech Laboratories Ltd.?

The Price-to-Earnings (PE) ratio of Zenotech Laboratories Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Zenotech Laboratories Ltd.?

Zenotech Laboratories Ltd. has a Return on Equity (ROE) of -1.12% and a Return on Capital Employed (ROCE) of 2.17% as per the latest financial reports.

What is the 52-week high and low of Zenotech Laboratories Ltd.?

The 52-week high of Zenotech Laboratories Ltd. is - and the 52-week low is -.

What is the dividend yield of Zenotech Laboratories Ltd.?

The dividend yield of Zenotech Laboratories Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Zenotech Laboratories Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.01% and retail/public investors hold 25.83% of Zenotech Laboratories Ltd. shares.

What sector does Zenotech Laboratories Ltd. belong to?

Zenotech Laboratories Ltd. operates in the Healthcare sector.

What is the beta of Zenotech Laboratories Ltd.?

The beta of Zenotech Laboratories Ltd. is 1.18, indicating its price volatility relative to the broader market. Over the past 1 year, Zenotech Laboratories Ltd. has delivered an absolute return of -30.81%.

What is the RSI of Zenotech Laboratories Ltd.?

The 14-day Relative Strength Index (RSI) of Zenotech Laboratories Ltd. is 47.26, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Zenotech Laboratories Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Zenotech Laboratories Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Company Profile

Corporate Actions